Correlation Between Bausch Health and Capricor Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bausch Health and Capricor Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bausch Health and Capricor Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bausch Health Companies and Capricor Therapeutics, you can compare the effects of market volatilities on Bausch Health and Capricor Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bausch Health with a short position of Capricor Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bausch Health and Capricor Therapeutics.
Diversification Opportunities for Bausch Health and Capricor Therapeutics
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Bausch and Capricor is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Bausch Health Companies and Capricor Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capricor Therapeutics and Bausch Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bausch Health Companies are associated (or correlated) with Capricor Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capricor Therapeutics has no effect on the direction of Bausch Health i.e., Bausch Health and Capricor Therapeutics go up and down completely randomly.
Pair Corralation between Bausch Health and Capricor Therapeutics
Considering the 90-day investment horizon Bausch Health Companies is expected to under-perform the Capricor Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Bausch Health Companies is 1.91 times less risky than Capricor Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Capricor Therapeutics is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 1,376 in Capricor Therapeutics on December 29, 2024 and sell it today you would lose (194.00) from holding Capricor Therapeutics or give up 14.1% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Bausch Health Companies vs. Capricor Therapeutics
Performance |
Timeline |
Bausch Health Companies |
Capricor Therapeutics |
Bausch Health and Capricor Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bausch Health and Capricor Therapeutics
The main advantage of trading using opposite Bausch Health and Capricor Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bausch Health position performs unexpectedly, Capricor Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will offset losses from the drop in Capricor Therapeutics' long position.Bausch Health vs. Viatris | Bausch Health vs. Tilray Inc | Bausch Health vs. Zoetis Inc | Bausch Health vs. Emergent Biosolutions |
Capricor Therapeutics vs. NextCure | Capricor Therapeutics vs. Pulmatrix | Capricor Therapeutics vs. Akari Therapeutics PLC | Capricor Therapeutics vs. Soleno Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |